Table 1.
Baseline participant characteristics by intervention arm
| iTAB (n = 25) | CTRL (n = 25) | p value | |
|---|---|---|---|
| Descriptive | |||
| Age; mean (SD) | 48.4 (9.2) | 45.9 (10.2) | 0.36 |
| Education; mean (SD) | 13.3 (2.2) | 13.0 (3.1) | 0.67 |
| Male; % (#) | 92.0 % [23] | 84.0 % [21] | 0.38 |
| Caucasian; % (#) | 64.0 % [16] | 44.0 % [11] | 0.16 |
| HCV infected; % (#) | 24.0 % [6] | 40.0 % [10] | 0.22 |
| Lifetime substance abuse/dependence; % (#) | |||
| Alcohol | 48.0 % [12] | 83.3 % [20] | <.01 |
| Marijuana | 32.0 % [8] | 37.5 % [9] | 0.69 |
| Cocaine | 40.0 % [10] | 45.8 % [11] | 0.68 |
| Opioid | 12.0 % [3] | 8.3 % [2] | 0.67 |
| Methamphetamine | 48.0 % [12] | 58.3 % [14] | 0.47 |
| HIV disease characteristics | |||
| CD4 count; median (IQR) (n = 40) | 463.5 (273.3, 912.0) | 613.5 (346.3, 959.8) | 0.47 |
| Nadir CD4 count; median (IQR) (n = 38) | 212 (94, 450) | 188 (98, 330) | 0.79 |
| HIV RNA plasma; median (IQR)a | 1.6 (1.6, 1.7) | 1.6 (1.6, 1.6) | 0.51 |
| Proportion undetectable % (#) b | 75.0 % [18] | 95.8 % [23] | 0.10 |
| AIDS % (#) | 66.7 % [14] | 60.9 % [14] | 0.69 |
| Psychiatric | |||
| Number non-ARV Medications; mean (SD) | 7.2 (4.7) | 6.4 (4.5) | 0.54 |
| YMRS; mean (SD) | 6.4 (7.6) | 5.2 (4.5) | 0.49 |
| BDI-II Total; mean (SD) | 17.0 (12.6) | 18.0 (10.6) | 0.77 |
| GAF; mean (SD) | 68.0 (10.0) | 67.3 (10.9) | 0.82 |
ART antiretroviral Therapy, BDI-II beck depression inventory-II, HCV hepatitis C virus, YMRS young mania rating scale, BDI-II beck depression inventory II, GAF global assessment of functioning, Nadir CD4 count is calculated as the lowest of self reported or laboratory generated value. IQR interquartile range
a
In log copies/ml
b
<50 cp/ml